Link Technologies Inks License for PNA's PNA Synthesis Tech | GenomeWeb
NEW YORK (GenomeWeb News) - Link Technologies has entered a non-exclusive license agreement with PNA Inventor Group that will allow it to manufacture and sell monomers for peptide nucleic acid synthesis worldwide.
 
Link Technologies said that numerous uses for PNAs have been identified or proposed for molecular biology applications, diagnostic assays, and antisense therapies.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.